
Overlap Results

Collection(s):	BP, C1, C6, CGP, CM, CP, CP:KEGG, MIR, TFT
# overlaps shown:	100
# genesets in collections:	7332
# genes in comparison (n):	250
# genes in universe (N):	45956

Gene Set Name	# Genes in Gene Set (K)	Description	# Genes in Overlap (k)	k/K	p-value	FDR q-value
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	456	Cluster 6 of method A: up-regulation of these genes in patients with non-small cell lung cancer (NSCLC) predicts poor survival outcome.	79	0.1732	3.17E-96	2.33E-92
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	570	Genes up-regulated during later stage of differentiation of Oli-Neu cells (oligodendroglial precursor) in response to PD174265 [PubChemID=4709].	78	0.1368	1.8E-86	6.58E-83
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	140	The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.	52	0.3714	3.76E-82	9.19E-79
DODD_NASOPHARYNGEAL_CARCINOMA_DN	1375	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	96	0.0698	2.57E-79	4.7E-76
MODULE_54	263	Genes in the cancer module 54	58	0.2205	1.68E-76	2.46E-73
KOBAYASHI_EGFR_SIGNALING_24HR_DN	251	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	57	0.2271	5.8E-76	7.09E-73
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	1278	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	89	0.0696	6.32E-73	6.61E-70
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	324	Genes up-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	57	0.1759	4.69E-69	4.3E-66
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	178	Top 200 marker genes up-regulated in the 'proliferation' subclass of hepatocellular carcinoma (HCC); characterized by increased proliferation, high levels of serum AFP [GeneID=174], and chromosomal instability.	48	0.2697	7.39E-68	6.02E-65
MARSON_BOUND_BY_E2F4_UNSTIMULATED	728	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	71	0.0975	1.26E-67	9.24E-65
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	151	Up-regulated genes whose expression correlated with histologic grade of invasive breast cancer tumors: comparison of grade 1 vs grade 3.	45	0.2980	7.52E-66	5.01E-63
HORIUCHI_WTAP_TARGETS_DN	310	Genes down-regulated in primary endothelial cells (HUVEC) after knockdown of WTAP [GeneID=9589] by RNAi.	54	0.1742	4.18E-65	2.56E-62
BASAKI_YBX1_TARGETS_UP	290	Genes up-regulated in SKOC-3 cells (ovarian cancer) after YB-1 (YBX1) [GeneID=4904] knockdown by RNAi.	53	0.1828	4.55E-65	2.57E-62
VECCHI_GASTRIC_CANCER_EARLY_UP	430	Up-regulated genes distinguishing between early gastric cancer (EGC) and normal tissue samples.	58	0.1349	3.25E-63	1.7E-60
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	663	Genes down-regulated in APL (acute promyeolocytic leukemia) blasts expressing PML-RARA fusion [GeneID=5371;5914] compared to normal promyeloblasts.	62	0.0935	1.34E-57	6.56E-55
BENPORATH_CYCLING_GENES	648	Genes showing cell-cycle stage-specific expression [PMID=12058064].	61	0.0941	8.12E-57	3.72E-54
KONG_E2F3_TARGETS	97	Genes up-regulated in MEF cells (embryonic fibroblasts) at 16 hr after serum stimulation and knockdown of E2F3 [GeneID=1871] by RNAi.	35	0.3608	1.03E-54	4.46E-52
CHANG_CYCLING_GENES	148	Fibroblast serum response genes showing periodic expression during the cell cycle; excluded from the core serum response signature.	39	0.2635	1.15E-54	4.7E-52
NUYTTEN_EZH2_TARGETS_DN	1024	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	69	0.0674	1.25E-54	4.83E-52
BERENJENO_TRANSFORMED_BY_RHOA_UP	536	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	55	0.1026	3.61E-53	1.32E-50
ODONNELL_TFRC_TARGETS_DN	139	Genes down-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) upon knockdown of TFRC [GeneID=7037] by RNAi.	36	0.2590	3.55E-50	1.24E-47
ZHANG_TLX_TARGETS_60HR_DN	277	Genes down-regulated in neural stem cells (NSC) at 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	43	0.1552	1.88E-49	6.27E-47
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	181	Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.	38	0.2099	4.44E-49	1.42E-46
LEE_EARLY_T_LYMPHOCYTE_UP	107	Genes up-regulated at early stages of progenitor T lymphocyte maturation compared to the late stages.	33	0.3084	6.35E-49	1.94E-46
GOLDRATH_ANTIGEN_RESPONSE	346	Genes up-regulated at the peak of an antigen response of naive CD8+ [GeneID=925;926] T-cells.	45	0.1301	3.86E-48	1.13E-45
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	633	Genes up-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	54	0.0853	7.76E-48	2.19E-45
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	722	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	56	0.0776	2.36E-47	6.41E-45
SMID_BREAST_CANCER_BASAL_UP	648	Genes up-regulated in basal subtype of breast cancer samles.	54	0.0833	2.73E-47	7.14E-45
CAIRO_HEPATOBLASTOMA_CLASSES_UP	605	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	52	0.0860	3.34E-46	8.44E-44
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	163	Genes up-regulated during differentiation from large pre-BII to small pre-BII lymphocyte.	35	0.2147	1.3E-45	3.18E-43
CROONQUIST_IL6_DEPRIVATION_DN	98	Genes down-regulated in the ANBL-6 cell line (multiple myeloma, MM) after withdrawal of IL6 [GeneID=3569].	30	0.3061	2.01E-44	4.76E-42
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	162	Genes from the 254-gene classifier which were up-regulated in melanoma patients with a reported distant metastasis within 4 years.	34	0.2099	5.93E-44	1.36E-41
BLUM_RESPONSE_TO_SALIRASIB_DN	342	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	42	0.1228	7.56E-44	1.68E-41
GAVIN_FOXP3_TARGETS_CLUSTER_P6	91	Cluster P6 of genes with similar expression profiles in peripheral T lymphocytes after FOXP3 [GeneID=50943] loss of function (LOF).	29	0.3187	1.46E-43	3.14E-41
MARKEY_RB1_ACUTE_LOF_DN	228	Genes down-regulated in adult fibroblasts with inactivated RB1 [GeneID=5925] by Cre-lox: acute loss of function (LOF) of RB1.	37	0.1623	2.47E-43	5.17E-41
WHITFIELD_CELL_CYCLE_G2_M	216	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G2/M phase of cell cycle.	36	0.1667	1.28E-42	2.62E-40
PUJANA_BRCA1_PCC_NETWORK	1652	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	69	0.0418	5.38E-41	1.07E-38
CROONQUIST_NRAS_SIGNALING_DN	72	Genes down-regulated in ANBL-6 cell line (multiple myeloma, MM)  expressing a constantly active form of NRAS [GeneID=4893] off a plasmid vector compared to those grown in the presence of IL6 [GeneID=3569].	26	0.3611	7.77E-41	1.5E-38
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	128	Cell cycle genes significantly (p =< 0.05) changed in fibroblast cells at 24 h after exposure to ionizing radiation.	30	0.2344	1.88E-40	3.54E-38
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	167	Genes up-regulated in genomically unstable Ewing's sarcoma tumors compared to the stable ones.	32	0.1916	5.01E-40	9.18E-38
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	87	Top 100 probe sets contrubuting to the positive side of the 2nd principal component; associated with adipocytic differentiation.	26	0.2989	2.7E-38	4.83E-36
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	277	Genes identified by method 2 as coordinately down-regulated late in HMEC cells (mammary epithelium) during acinar development in vitro.	35	0.1264	4.84E-37	8.45E-35
PUJANA_CHEK2_PCC_NETWORK	779	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC >= 0.4) with that of CHEK2 [GeneID=11200].	49	0.0629	5.3E-37	9.04E-35
ZHANG_TLX_TARGETS_36HR_DN	185	Genes down-regulated in neural stem cells (NSC) at 36 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	31	0.1676	7.33E-37	1.22E-34
PATIL_LIVER_CANCER	747	Genes up-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	48	0.0643	1.14E-36	1.86E-34
KANG_DOXORUBICIN_RESISTANCE_UP	54	Genes up-regulated in gastric cancer cell lines: doxorubicin [PubChem=31703] resistant vs sensitive.	22	0.4074	3.97E-36	6.23E-34
ZHAN_MULTIPLE_MYELOMA_PR_UP	45	Top 50 up-regulated genes in cluster PR of multiple myeloma samples characterized by increased expression of proliferation and cell cycle genes.	21	0.4667	3.99E-36	6.23E-34
KRIEG_HYPOXIA_NOT_VIA_KDM3A	770	Genes induced under hypoxia independently of KDM3A [GeneID=55818] in RCC4 cells (renal carcinoma) expressing VHL [GeneID=7428].	48	0.0623	4.64E-36	7.08E-34
PUJANA_BRCA2_PCC_NETWORK	423	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC >= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	39	0.0922	8.27E-36	1.24E-33
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	122	Genes down-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	27	0.2213	9.59E-36	1.41E-33
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	146	Genes up-regulated in CD4+ [GeneID=920] T lymphocytes after stimulation with prostaglandin E2 [PubChem=5280360].	28	0.1918	3.92E-35	5.64E-33
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	294	Genes up-regulated in nsopharyngeal carcinoma relative to the normal tissue.	34	0.1156	1.17E-34	1.65E-32
REACTOME_CELL_CYCLE	421	Genes involved in Cell Cycle	38	0.0903	1.5E-34	2.07E-32
BURTON_ADIPOGENESIS_3	101	Strongly up-regulated at 16-24 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes.	25	0.2475	1.61E-34	2.18E-32
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	87	Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	24	0.2759	1.85E-34	2.46E-32
WONG_EMBRYONIC_STEM_CELL_CORE	335	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	35	0.1045	4.3E-34	5.64E-32
MORI_IMMATURE_B_LYMPHOCYTE_DN	90	Down-regulated genes in the B lymphocyte developmental signature based on expression profiling of lymphomas from the Emu-myc transgenic mice: the immature B stage.	24	0.2667	4.67E-34	6.01E-32
FUJII_YBX1_TARGETS_DN	202	Genes down-regulated in MCF-7 cells (breast cancer) after knockdown of YBX1 [GeneID=4904] by RNAi.	30	0.1485	4.89E-34	6.19E-32
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	180	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	29	0.1611	5.21E-34	6.48E-32
MITSIADES_RESPONSE_TO_APLIDIN_DN	249	Genes down-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	31	0.1245	1.11E-32	1.36E-30
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	250	The glioblastoma multiforme (GBM) plasticity signature: genes up-regulated in neural stem cells (NSC) with double knockout of TP53 and PTEN [GeneID=7157;5728] vs those with knockout of TP53 alone.	31	0.1240	1.27E-32	1.52E-30
FURUKAWA_DUSP6_TARGETS_PCI35_DN	74	Genes down-regulated in PCI-35 cells (pancreatic cancer, lack endogenous DUSP6 [GeneID=1848]) upon expression of DUSP6 off an adenoviral vector.	22	0.2973	1.69E-32	1.99E-30
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	374	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	35	0.0936	2.07E-32	2.41E-30
MODULE_118	410	Genes in the cancer module 118	36	0.0878	2.51E-32	2.87E-30
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	163	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	27	0.1656	4.53E-32	5.11E-30
WEST_ADRENOCORTICAL_TUMOR_UP	294	Up-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	32	0.1088	8.39E-32	9.33E-30
MODULE_52	433	Genes in the cancer module 52	36	0.0831	1.75E-31	1.92E-29
WHITEFORD_PEDIATRIC_CANCER_MARKERS	116	Differentially expressed genes in a panel of xenografts representing 8 common pediatric tumors compared to the normal tissues.	24	0.2069	4.13E-31	4.45E-29
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	378	Down-regulated genes whose expression profile is specific to Custer I of urothelial cell carcinoma (UCC) tumors.	34	0.0899	6.43E-31	6.83E-29
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	185	Human orthologs of genes down-regulated in the crb ('crash and burn') zebrafish mutant that represents a loss-of-function mutation in BMYB [GeneID=4605].	27	0.1459	1.66E-30	1.74E-28
JOHNSTONE_PARVB_TARGETS_3_DN	918	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	46	0.0501	2.07E-30	2.14E-28
REACTOME_CELL_CYCLE_MITOTIC	325	Genes involved in Cell Cycle, Mitotic	32	0.0985	2.14E-30	2.18E-28
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	329	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	32	0.0973	3.16E-30	3.18E-28
LE_EGR2_TARGETS_UP	108	Genes up-regulated in P14 nerves of transgenic mice having hypomorhic (reduced function) allele of EGR2 [GeneID=1959].	23	0.2130	3.57E-30	3.53E-28
FEVR_CTNNB1_TARGETS_DN	553	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	38	0.0687	3.97E-30	3.88E-28
BENPORATH_PROLIFERATION	147	Set 'Proliferation Cluster': genes defined in human breast tumor expression data.	25	0.1701	4.52E-30	4.36E-28
MODULE_198	303	Genes in the cancer module 198	31	0.1023	5.45E-30	5.19E-28
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	309	Genes down-regulated in mature plasma cells compared with plasmablastic B lymphocytes.	31	0.1003	1.01E-29	9.45E-28
MODULE_18	451	Genes in the cancer module 18	35	0.0776	1.36E-29	1.26E-27
KIM_WT1_TARGETS_DN	459	Genes down-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	35	0.0763	2.48E-29	2.27E-27
TANG_SENESCENCE_TP53_TARGETS_DN	57	Genes down-regulated in WI-38 cells (senescent primary fibroblasts) after inactivation of TP53 [GeneID=7157] by GSE56 polypeptide.	19	0.3333	2.5E-29	2.27E-27
POOLA_INVASIVE_BREAST_CANCER_UP	288	Genes up-regulated in atypical ductal hyperplastic tissues from patients with (ADHC) breast cancer vs those without the cancer (ADH).	30	0.1042	2.76E-29	2.47E-27
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	58	Genes commonly down-regulated in SK-N-BE cells (neuroblastoma) after RNAi knockdown of CCND1 and CDK4 [GeneID=595;1019].	19	0.3276	3.7E-29	3.27E-27
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	362	Genes down-regulated in ALL (acute lymphoblastic leukemia) blasts after 1 week of treatment with glucocorticoids.	32	0.0884	6.7E-29	5.85E-27
RUIZ_TNC_TARGETS_DN	142	Genes down-regulated in T98G cells (glioblastoma) by TNC [GeneID=3371].	24	0.1690	7.69E-29	6.64E-27
BIDUS_METASTASIS_UP	214	Genes up-regulated in endometroid endometrial tumors from patients with lymph node metastases compared to those without the metastases.	27	0.1262	9.79E-29	8.35E-27
BENPORATH_ES_1	379	Set 'ES exp1': genes overexpressed in human embryonic stem cells according to 5 or more out of 20 profiling studies.	32	0.0844	2.87E-28	2.42E-26
MODULE_3	385	Genes in the cancer module 3	32	0.0831	4.71E-28	3.93E-26
MODULE_98	393	Genes in the cancer module 98	32	0.0814	9.02E-28	7.43E-26
GEORGES_TARGETS_OF_MIR192_AND_MIR215	893	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	43	0.0482	9.75E-28	7.95E-26
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	55	Genes downstream of both CDKN1A and TP53 [GeneID=1026;7157] in 2774qw1 cells (ovarian cancer).	18	0.3273	1.13E-27	9.07E-26
MODULE_252	237	Genes in the cancer module 252	27	0.1139	1.64E-27	1.31E-25
RHODES_UNDIFFERENTIATED_CANCER	69	Genes commonly up-regulated in undifferentiated cancer relative to well-differentiated cancer, based on the meta-analysis of the OncoMine gene expression database.	19	0.2754	1.72E-27	1.35E-25
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	85	Cell cycle genes significantly (p =< 0.05) changed in fibroblast cells at 6 h after exposure to ionizing radiation.	20	0.2353	2.44E-27	1.9E-25
REICHERT_MITOSIS_LIN9_TARGETS	28	Genes with known mitosis function that were down-regulated in MEF cells (embryonic fibroblast) upon knockout of LIN9 [GeneID=286826].	15	0.5357	2.48E-27	1.92E-25
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	86	Up-regulated genes in the B lymphocyte developmental signature, based on expression profiling of lymphomas from the Emu-myc transgenic mice: the  Large Pre-BII stage.	20	0.2326	3.16E-27	2.42E-25
CHICAS_RB1_TARGETS_GROWING	243	Genes up-regulated in growing IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	27	0.1111	3.27E-27	2.47E-25
ZHANG_TLX_TARGETS_UP	89	Genes up-regulated in neural stem cells (NSC) at both 36 h and 60 h after cre-lox knockout of TLX (NR2E1) [GeneID=7101].	20	0.2247	6.76E-27	5.06E-25
WILCOX_RESPONSE_TO_PROGESTERONE_UP	152	Genes up-regulated in primary cultures of ovarian surface epithlium cells exposed to progesterone [PubChem=5994] for 5 days.	23	0.1513	1.62E-26	1.2E-24
AFFAR_YY1_TARGETS_DN	234	Genes down-regulated in MEF cells (embryonic fibroblast) expressing ~25% of YY1 [GeneID=7528].	26	0.1111	3.06E-26	2.24E-24


Gene/Gene Set Overlap Matrix

Entrez Gene Id	Gene Symbol	Gene Description	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3	MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	MODULE_252	RHODES_UNDIFFERENTIATED_CANCER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING	ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
701	BUB1B	budding uninhibited by benzimidazoles 1 homolog beta (yeast)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES			ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6			PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN					PUJANA_CHEK2_PCC_NETWORK			KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52			SHEPARD_CRUSH_AND_BURN_MUTANT_DN		REACTOME_CELL_CYCLE_MITOTIC			FEVR_CTNNB1_TARGETS_DN				MODULE_18	KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN			BENPORATH_ES_1	MODULE_3		GEORGES_TARGETS_OF_MIR192_AND_MIR215							CHICAS_RB1_TARGETS_GROWING			AFFAR_YY1_TARGETS_DN
55165	CEP55	centrosomal protein 55kDa	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP				WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP			ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN				SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			FURUKAWA_DUSP6_TARGETS_PCI35_DN								SHEPARD_CRUSH_AND_BURN_MUTANT_DN			LINDGREN_BLADDER_CANCER_CLUSTER_3_UP							KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN						GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	REICHERT_MITOSIS_LIN9_TARGETS			ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	
983	CDK1	cyclin-dependent kinase 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN			CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP					MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3	MODULE_98		WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	MODULE_252	RHODES_UNDIFFERENTIATED_CANCER			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP			WILCOX_RESPONSE_TO_PROGESTERONE_UP	
259266	ASPM	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP			WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6					ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2				KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP				CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP							FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP					WEST_ADRENOCORTICAL_TUMOR_UP				SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN					BENPORATH_PROLIFERATION				KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP								GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53				REICHERT_MITOSIS_LIN9_TARGETS		CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
22974	TPX2	TPX2, microtubule-associated, homolog (Xenopus laevis)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN				GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP				RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP									MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS		SHEPARD_CRUSH_AND_BURN_MUTANT_DN									MODULE_18		TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN			BIDUS_METASTASIS_UP		MODULE_3			WU_APOPTOSIS_BY_CDKN1A_VIA_TP53						CHICAS_RB1_TARGETS_GROWING			
11004	KIF2C	kinesin family member 2C	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK				REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN							FURUKAWA_DUSP6_TARGETS_PCI35_DN			LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP			MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN		RUIZ_TNC_TARGETS_DN		BENPORATH_ES_1		MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER		REICHERT_MITOSIS_LIN9_TARGETS					AFFAR_YY1_TARGETS_DN
9787	DLGAP5	discs, large (Drosophila) homolog-associated protein 5	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP			MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER		ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN			MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP				BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3		GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53		RHODES_UNDIFFERENTIATED_CANCER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR					WILCOX_RESPONSE_TO_PROGESTERONE_UP	
51203	NUSAP1	nucleolar and spindle associated protein 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES		BERENJENO_TRANSFORMED_BY_RHOA_UP			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2		ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN						WHITEFORD_PEDIATRIC_CANCER_MARKERS			JOHNSTONE_PARVB_TARGETS_3_DN			LE_EGR2_TARGETS_UP						KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP								ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	REICHERT_MITOSIS_LIN9_TARGETS		CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	
3832	KIF11	kinesin family member 11	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS			BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP				TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP		MODULE_3						ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR				ZHANG_TLX_TARGETS_UP		
9493	KIF23	kinesin family member 23	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP									CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP				ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE			WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN		MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN								MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252	RHODES_UNDIFFERENTIATED_CANCER		REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				AFFAR_YY1_TARGETS_DN
4288	MKI67	antigen identified by monoclonal antibody Ki-67	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS			BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN		LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN			NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN		KANG_DOXORUBICIN_RESISTANCE_UP			PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP			BURTON_ADIPOGENESIS_3			MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN				MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			WHITEFORD_PEDIATRIC_CANCER_MARKERS		SHEPARD_CRUSH_AND_BURN_MUTANT_DN				LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN												GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53				REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		ZHANG_TLX_TARGETS_UP		AFFAR_YY1_TARGETS_DN
4001	LMNB1	lamin B1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN				BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP					CROONQUIST_IL6_DEPRIVATION_DN						PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK			KANG_DOXORUBICIN_RESISTANCE_UP			PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE			WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN			ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52							LE_EGR2_TARGETS_UP			MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18		TANG_SENESCENCE_TP53_TARGETS_DN					BIDUS_METASTASIS_UP		MODULE_3	MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				
6241	RRM2	ribonucleotide reductase M2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK				NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118		WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3								MORI_LARGE_PRE_BII_LYMPHOCYTE_UP			WILCOX_RESPONSE_TO_PROGESTERONE_UP	
7298	TYMS	thymidylate synthetase	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP				HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP			CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6			PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN				SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN					WHITEFORD_PEDIATRIC_CANCER_MARKERS			JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18			POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP		MODULE_3			WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	
4751	NEK2	NIMA (never in mitosis gene a)-related kinase 2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP				PATIL_LIVER_CANCER		ZHAN_MULTIPLE_MYELOMA_PR_UP			MISSIAGLIA_REGULATED_BY_METHYLATION_DN			REACTOME_CELL_CYCLE			WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN			MITSIADES_RESPONSE_TO_APLIDIN_DN						WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			BENPORATH_PROLIFERATION	MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP							MODULE_98			MODULE_252		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR			CHICAS_RB1_TARGETS_GROWING			
10403	NDC80	NDC80 homolog, kinetochore complex component (S. cerevisiae)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP		FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118							JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC				BENPORATH_PROLIFERATION	MODULE_198			KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP							MODULE_98			MODULE_252							WILCOX_RESPONSE_TO_PROGESTERONE_UP	
55355	HJURP	Holliday junction recognition protein	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN							CAIRO_HEPATOBLASTOMA_CLASSES_UP											FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2			PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP		KRIEG_HYPOXIA_NOT_VIA_KDM3A			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE							MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN																		KIM_WT1_TARGETS_DN			MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN		RUIZ_TNC_TARGETS_DN					GEORGES_TARGETS_OF_MIR192_AND_MIR215									WILCOX_RESPONSE_TO_PROGESTERONE_UP	
891	CCNB1	cyclin B1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK				ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3			MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118		WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN		REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP			MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18							BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3	MODULE_98		WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	MODULE_252	RHODES_UNDIFFERENTIATED_CANCER		REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	
3161	HMMR	hyaluronan-mediated motility receptor (RHAMM)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			PUJANA_BRCA2_PCC_NETWORK								MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP					MODULE_118			MODULE_52											TARTE_PLASMA_CELL_VS_PLASMABLAST_DN						RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN			BENPORATH_ES_1			GEORGES_TARGETS_OF_MIR192_AND_MIR215					REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING	ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
3838	KPNA2	karyopherin alpha 2 (RAG cohort 1, importin alpha 1)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES				BERENJENO_TRANSFORMED_BY_RHOA_UP			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER		ZHAN_MULTIPLE_MYELOMA_PR_UP							BURTON_ADIPOGENESIS_3		WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN								LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN									BENPORATH_ES_1						RHODES_UNDIFFERENTIATED_CANCER			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				
890	CCNA2	cyclin A2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118			MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS			JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC		LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN		MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP			RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3	MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING	ZHANG_TLX_TARGETS_UP		AFFAR_YY1_TARGETS_DN
55872	PBK	PDZ binding kinase	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP				BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M					NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP				PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP						SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP										FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN			WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS			JOHNSTONE_PARVB_TARGETS_3_DN					BENPORATH_PROLIFERATION					TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP			RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP					WU_APOPTOSIS_BY_CDKN1A_VIA_TP53								WILCOX_RESPONSE_TO_PROGESTERONE_UP	
3015	H2AFZ	H2A histone family, member Z	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN				MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP									BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP							BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP		FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK							MISSIAGLIA_REGULATED_BY_METHYLATION_DN			REACTOME_CELL_CYCLE										WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198									BIDUS_METASTASIS_UP			MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER							
9133	CCNB2	cyclin B2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE			SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK				ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN				ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN		REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198				TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP		MODULE_3	MODULE_98			MODULE_252				MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
2305	FOXM1	forkhead box M1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP			CROONQUIST_IL6_DEPRIVATION_DN					WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN				FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK			KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN								FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN				MODULE_118		WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52			SHEPARD_CRUSH_AND_BURN_MUTANT_DN					FEVR_CTNNB1_TARGETS_DN		MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18						RUIZ_TNC_TARGETS_DN			MODULE_3	MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER				CHICAS_RB1_TARGETS_GROWING			AFFAR_YY1_TARGETS_DN
1111	CHEK1	CHK1 checkpoint homolog (S. pombe)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN		SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN																	FEVR_CTNNB1_TARGETS_DN		MODULE_198							RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP	BENPORATH_ES_1		MODULE_98		WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP		
9768	KIAA0101	KIAA0101	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP			GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK			KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN					MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52							LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18			POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN				MODULE_3					RHODES_UNDIFFERENTIATED_CANCER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR			CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	
1063	CENPF	centromere protein F, 350/400kDa (mitosin)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP			VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP								MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP			BENPORATH_PROLIFERATION	MODULE_198			KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN			BIDUS_METASTASIS_UP			MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252			REICHERT_MITOSIS_LIN9_TARGETS		CHICAS_RB1_TARGETS_GROWING	ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	
1062	CENPE	centromere protein E, 312kDa	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54				CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP				CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN			GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN					PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP							SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP									WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN								MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252			REICHERT_MITOSIS_LIN9_TARGETS	MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				AFFAR_YY1_TARGETS_DN
9055	PRC1	protein regulator of cytokinesis 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			FOURNIER_ACINAR_DEVELOPMENT_LATE_2		ZHANG_TLX_TARGETS_36HR_DN		KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A		MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN		MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN				WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION					TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN							WU_APOPTOSIS_BY_CDKN1A_VIA_TP53					MORI_LARGE_PRE_BII_LYMPHOCYTE_UP			WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
24137	KIF4A	kinesin family member 4A	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN							FOURNIER_ACINAR_DEVELOPMENT_LATE_2				KANG_DOXORUBICIN_RESISTANCE_UP								BURTON_ADIPOGENESIS_3		WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP								LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP								TANG_SENESCENCE_TP53_TARGETS_DN		MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN			BIDUS_METASTASIS_UP	BENPORATH_ES_1										CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	
29127	RACGAP1	Rac GTPase activating protein 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP			KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP			MARKEY_RB1_ACUTE_LOF_DN				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			FOURNIER_ACINAR_DEVELOPMENT_LATE_2					ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE				MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN				WEST_ADRENOCORTICAL_TUMOR_UP			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION				KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN			RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				AFFAR_YY1_TARGETS_DN
55215	FANCI	Fanconi anemia, complementation group I	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN						PUJANA_BRCA1_PCC_NETWORK					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN		KANG_DOXORUBICIN_RESISTANCE_UP	ZHAN_MULTIPLE_MYELOMA_PR_UP	KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP						FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN					LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP					JOHNSTONE_PARVB_TARGETS_3_DN											POOLA_INVASIVE_BREAST_CANCER_UP			RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	
51514	DTL	denticleless homolog (Drosophila)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN		LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP						MARKEY_RB1_ACUTE_LOF_DN							FOURNIER_ACINAR_DEVELOPMENT_LATE_2		ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP		BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP			FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN			WEST_ADRENOCORTICAL_TUMOR_UP					JOHNSTONE_PARVB_TARGETS_3_DN					BENPORATH_PROLIFERATION						POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN					GEORGES_TARGETS_OF_MIR192_AND_MIR215				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP		ZHANG_TLX_TARGETS_UP		
64151	NCAPG	non-SMC condensin I complex, subunit G	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		KONG_E2F3_TARGETS					ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP			WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6						FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP				ZHANG_TLX_TARGETS_36HR_DN		KANG_DOXORUBICIN_RESISTANCE_UP					CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP			GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN					MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN								JOHNSTONE_PARVB_TARGETS_3_DN					BENPORATH_PROLIFERATION				KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP		RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN							WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
11339	OIP5	Opa interacting protein 5	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP						NUYTTEN_EZH2_TARGETS_DN				GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP					CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN						PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN					PUJANA_CHEK2_PCC_NETWORK			KANG_DOXORUBICIN_RESISTANCE_UP		KRIEG_HYPOXIA_NOT_VIA_KDM3A					REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			FUJII_YBX1_TARGETS_DN												SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN									KIM_WT1_TARGETS_DN		POOLA_INVASIVE_BREAST_CANCER_UP			RUIZ_TNC_TARGETS_DN		BENPORATH_ES_1													
10112	KIF20A	kinesin family member 20A	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN					CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN		KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP										CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3		WONG_EMBRYONIC_STEM_CELL_CORE										WEST_ADRENOCORTICAL_TUMOR_UP						REACTOME_CELL_CYCLE_MITOTIC		LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN					KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	REICHERT_MITOSIS_LIN9_TARGETS		CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
991	CDC20	cell division cycle 20 homolog (S. cerevisiae)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE		RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6		WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR		NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			PUJANA_BRCA2_PCC_NETWORK				REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN				ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52			SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC		LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18	KIM_WT1_TARGETS_DN	TANG_SENESCENCE_TP53_TARGETS_DN	POOLA_INVASIVE_BREAST_CANCER_UP					BENPORATH_ES_1	MODULE_3		GEORGES_TARGETS_OF_MIR192_AND_MIR215			RHODES_UNDIFFERENTIATED_CANCER			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING		WILCOX_RESPONSE_TO_PROGESTERONE_UP	
79801	SHCBP1	SHC SH2-domain binding protein 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP				WINNEPENNINCKX_MELANOMA_METASTASIS_UP				WHITFIELD_CELL_CYCLE_G2_M								ZHANG_TLX_TARGETS_36HR_DN														FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP	FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN							SHEPARD_CRUSH_AND_BURN_MUTANT_DN	JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN					KIM_WT1_TARGETS_DN				RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN													ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	AFFAR_YY1_TARGETS_DN
3014	H2AFX	H2A histone family, member X	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN				GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP					MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR						PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK				REACTOME_CELL_CYCLE				MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP				WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118			MODULE_52	WHITEFORD_PEDIATRIC_CANCER_MARKERS						LE_EGR2_TARGETS_UP			MODULE_198		MODULE_18						RUIZ_TNC_TARGETS_DN			MODULE_3	MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				
10460	TACC3	transforming, acidic coiled-coil containing protein 3	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP					BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE								BLUM_RESPONSE_TO_SALIRASIB_DN			WHITFIELD_CELL_CYCLE_G2_M									PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A						BURTON_ADIPOGENESIS_3					SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN									LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN			LINDGREN_BLADDER_CANCER_CLUSTER_3_UP																											AFFAR_YY1_TARGETS_DN
51512	GTSE1	G-2 and S-phase expressed 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN				GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP		SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP							WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK				NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP		PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK		CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP					WONG_EMBRYONIC_STEM_CELL_CORE								MODULE_118			MODULE_52		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN									MODULE_18	KIM_WT1_TARGETS_DN																	CHICAS_RB1_TARGETS_GROWING			
83461	CDCA3	cell division cycle associated 3	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER			KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN					LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE			SMID_BREAST_CANCER_BASAL_UP		HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP				GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M						FOURNIER_ACINAR_DEVELOPMENT_LATE_2														WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN				ZHENG_GLIOBLASTOMA_PLASTICITY_UP					WEST_ADRENOCORTICAL_TUMOR_UP				SHEPARD_CRUSH_AND_BURN_MUTANT_DN										KIM_WT1_TARGETS_DN																MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				AFFAR_YY1_TARGETS_DN
55055	ZWILCH	Zwilch, kinetochore associated, homolog (Drosophila)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP						NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP															ZHANG_TLX_TARGETS_36HR_DN	PATIL_LIVER_CANCER		ZHAN_MULTIPLE_MYELOMA_PR_UP						REACTOME_CELL_CYCLE													WEST_ADRENOCORTICAL_TUMOR_UP					JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC													RUIZ_TNC_TARGETS_DN													ZHANG_TLX_TARGETS_UP		
55635	DEPDC1	DEP domain containing 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP			KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			FOURNIER_ACINAR_DEVELOPMENT_LATE_2		ZHANG_TLX_TARGETS_36HR_DN														FUJII_YBX1_TARGETS_DN											LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP													BIDUS_METASTASIS_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215							CHICAS_RB1_TARGETS_GROWING			
1033	CDKN3	cyclin-dependent kinase inhibitor 3	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	LEE_EARLY_T_LYMPHOCYTE_UP	GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	FOURNIER_ACINAR_DEVELOPMENT_LATE_2			PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP			PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP				GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN						MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52								FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN				POOLA_INVASIVE_BREAST_CANCER_UP						MODULE_3		GEORGES_TARGETS_OF_MIR192_AND_MIR215			RHODES_UNDIFFERENTIATED_CANCER			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	CHICAS_RB1_TARGETS_GROWING			
54478	FAM64A	family with sequence similarity 64, member A	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN				BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN													MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR												CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP																													KIM_WT1_TARGETS_DN							BENPORATH_ES_1							ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR						
995	CDC25C	cell division cycle 25 homolog C (S. pombe)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED					CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN		MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN											PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN			REACTOME_CELL_CYCLE					FUJII_YBX1_TARGETS_DN							LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP						REACTOME_CELL_CYCLE_MITOTIC			FEVR_CTNNB1_TARGETS_DN		MODULE_198												MODULE_98			MODULE_252								AFFAR_YY1_TARGETS_DN
9156	EXO1	exonuclease 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP					BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN						SMID_BREAST_CANCER_BASAL_UP				WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR				PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN												WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN						LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION									RUIZ_TNC_TARGETS_DN						WU_APOPTOSIS_BY_CDKN1A_VIA_TP53			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR				ZHANG_TLX_TARGETS_UP		AFFAR_YY1_TARGETS_DN
11169	WDHD1	WD repeat and HMG-box DNA binding protein 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP					BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP							PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN					PUJANA_BRCA2_PCC_NETWORK			SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP				WONG_EMBRYONIC_STEM_CELL_CORE													LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN		LINDGREN_BLADDER_CANCER_CLUSTER_3_UP													BIDUS_METASTASIS_UP	BENPORATH_ES_1				WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	MODULE_252		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR				ZHANG_TLX_TARGETS_UP	WILCOX_RESPONSE_TO_PROGESTERONE_UP	
81930	KIF18A	kinesin family member 18A	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP											FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP				ZHANG_TLX_TARGETS_36HR_DN									REACTOME_CELL_CYCLE								ZHENG_GLIOBLASTOMA_PLASTICITY_UP										JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC			FEVR_CTNNB1_TARGETS_DN					KIM_WT1_TARGETS_DN										GEORGES_TARGETS_OF_MIR192_AND_MIR215										
9918	NCAPD2	non-SMC condensin I complex, subunit D2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN							CAIRO_HEPATOBLASTOMA_CLASSES_UP							WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK							WONG_EMBRYONIC_STEM_CELL_CORE				MITSIADES_RESPONSE_TO_APLIDIN_DN		FURUKAWA_DUSP6_TARGETS_PCI35_DN		MODULE_118											FEVR_CTNNB1_TARGETS_DN		MODULE_198												MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER		REICHERT_MITOSIS_LIN9_TARGETS					
81620	CDT1	chromatin licensing and DNA replication factor 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP				KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED									NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN						SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP						MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK					KRIEG_HYPOXIA_NOT_VIA_KDM3A	PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN			REACTOME_CELL_CYCLE					FUJII_YBX1_TARGETS_DN		MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP								LINDGREN_BLADDER_CANCER_CLUSTER_1_DN			REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP		FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION											BENPORATH_ES_1							ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR						AFFAR_YY1_TARGETS_DN
57405	SPC25	SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP				KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN					KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP								CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6			PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN	ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK	ZHANG_TLX_TARGETS_36HR_DN			ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK				REACTOME_CELL_CYCLE					FUJII_YBX1_TARGETS_DN			ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN								JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC										POOLA_INVASIVE_BREAST_CANCER_UP	MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN		RUIZ_TNC_TARGETS_DN		BENPORATH_ES_1													
9928	KIF14	kinesin family member 14	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP		SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN			LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN					WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK				ZHAN_MULTIPLE_MYELOMA_PR_UP		PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN										MITSIADES_RESPONSE_TO_APLIDIN_DN				MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN			LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN										GEORGES_TARGETS_OF_MIR192_AND_MIR215			RHODES_UNDIFFERENTIATED_CANCER				CHICAS_RB1_TARGETS_GROWING			
3159	HMGA1	high mobility group AT-hook 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6		ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54							HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP														SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN						PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN							PATIL_LIVER_CANCER																									SHEPARD_CRUSH_AND_BURN_MUTANT_DN														RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN			BENPORATH_ES_1													
993	CDC25A	cell division cycle 25 homolog A (S. pombe)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP				CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN		LEE_EARLY_T_LYMPHOCYTE_UP				SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK					FOURNIER_ACINAR_DEVELOPMENT_LATE_2			PATIL_LIVER_CANCER								REACTOME_CELL_CYCLE		GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			FUJII_YBX1_TARGETS_DN					WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN			WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN			REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP								TANG_SENESCENCE_TP53_TARGETS_DN			RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	RUIZ_TNC_TARGETS_DN		BENPORATH_ES_1			GEORGES_TARGETS_OF_MIR192_AND_MIR215										
10606	PAICS	phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN											RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					WINNEPENNINCKX_MELANOMA_METASTASIS_UP					PUJANA_BRCA1_PCC_NETWORK		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP													MODULE_118			MODULE_52				JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18					RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN			BENPORATH_ES_1	MODULE_3						ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR						
6566	SLC16A1	solute carrier family 16, member 1 (monocarboxylic acid transporter 1)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP									PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK					KRIEG_HYPOXIA_NOT_VIA_KDM3A			CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP					WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN						WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP												TARTE_PLASMA_CELL_VS_PLASMABLAST_DN									BENPORATH_ES_1						RHODES_UNDIFFERENTIATED_CANCER							
2288	FKBP4	FK506 binding protein 4, 59kDa	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN				DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP							CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP																						FOURNIER_ACINAR_DEVELOPMENT_LATE_2																					WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																					
23468	CBX5	chromobox homolog 5	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN				DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP												BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP					MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK																							MITSIADES_RESPONSE_TO_APLIDIN_DN					LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN						JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN		MODULE_198	TARTE_PLASMA_CELL_VS_PLASMABLAST_DN									BENPORATH_ES_1		MODULE_98			MODULE_252					CHICAS_RB1_TARGETS_GROWING			
2597	GAPDH	glyceraldehyde-3-phosphate dehydrogenase	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN											CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE												PUJANA_BRCA1_PCC_NETWORK											KRIEG_HYPOXIA_NOT_VIA_KDM3A																		WEST_ADRENOCORTICAL_TUMOR_UP		WHITEFORD_PEDIATRIC_CANCER_MARKERS																RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN																
94081	SFXN1	sideroflexin 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN											CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN								GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP			RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																										SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP											WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN								JOHNSTONE_PARVB_TARGETS_3_DN																													AFFAR_YY1_TARGETS_DN
8767	RIPK2	receptor-interacting serine-threonine kinase 2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6			DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																																																																
6627	SNRPA1	small nuclear ribonucleoprotein polypeptide A'	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6				MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP						BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP											CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN		FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP		FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK							WONG_EMBRYONIC_STEM_CELL_CORE									LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	WEST_ADRENOCORTICAL_TUMOR_UP					JOHNSTONE_PARVB_TARGETS_3_DN						MODULE_198			KIM_WT1_TARGETS_DN									MODULE_98			MODULE_252								
5214	PFKP	phosphofructokinase, platelet	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6				MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP							VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN													SMID_BREAST_CANCER_BASAL_UP																				KRIEG_HYPOXIA_NOT_VIA_KDM3A													ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN										FEVR_CTNNB1_TARGETS_DN			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN							RUIZ_TNC_TARGETS_DN															
9123	SLC16A3	solute carrier family 16, member 3 (monocarboxylic acid transporter 4)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6				MODULE_54				CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP						CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP														NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP																							MODULE_118			MODULE_52												MODULE_18			POOLA_INVASIVE_BREAST_CANCER_UP						MODULE_3												
6781	STC1	stanniocalcin 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6					KOBAYASHI_EGFR_SIGNALING_24HR_DN		DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																					PATIL_LIVER_CANCER																					WEST_ADRENOCORTICAL_TUMOR_UP																																		
55907	CMAS	cytidine monophosphate N-acetylneuraminic acid synthetase	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN				NUYTTEN_EZH2_TARGETS_DN																																																																																	
30001	ERO1L	ERO1-like (S. cerevisiae)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN							ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																					WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																					
7004	TEAD4	TEA domain family member 4	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																					SMID_BREAST_CANCER_BASAL_UP														FOURNIER_ACINAR_DEVELOPMENT_LATE_2																																													BENPORATH_ES_1													
5318	PKP2	plakophilin 2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6						KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																																																																													
6513	SLC2A1	solute carrier family 2 (facilitated glucose transporter), member 1	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6							DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP												BERENJENO_TRANSFORMED_BY_RHOA_UP						RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																					KRIEG_HYPOXIA_NOT_VIA_KDM3A								WONG_EMBRYONIC_STEM_CELL_CORE							WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118			MODULE_52												MODULE_18																					
5352	PLOD2	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6														CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN													SMID_BREAST_CANCER_BASAL_UP				WINNEPENNINCKX_MELANOMA_METASTASIS_UP	BLUM_RESPONSE_TO_SALIRASIB_DN					CROONQUIST_NRAS_SIGNALING_DN										KRIEG_HYPOXIA_NOT_VIA_KDM3A																MODULE_118			MODULE_52												MODULE_18	KIM_WT1_TARGETS_DN						BIDUS_METASTASIS_UP		MODULE_3												
133	ADM	adrenomedullin	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																			BERENJENO_TRANSFORMED_BY_RHOA_UP								SMID_BREAST_CANCER_BASAL_UP																																																																								
8601	RGS20	regulator of G-protein signaling 20	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																											SMID_BREAST_CANCER_BASAL_UP																																																									RUIZ_TNC_TARGETS_DN															
2861	GPR37	G protein-coupled receptor 37 (endothelin receptor type B-like)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																											SMID_BREAST_CANCER_BASAL_UP																																																														GEORGES_TARGETS_OF_MIR192_AND_MIR215										
112399	EGLN3	egl nine homolog 3 (C. elegans)	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																																											ZHANG_TLX_TARGETS_36HR_DN																																											BENPORATH_ES_1													
3856	KRT8	keratin 8	SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6																																																																																						BENPORATH_ES_1													
2237	FEN1	flap structure-specific endonuclease 1		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES		BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP		FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK				REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN			FUJII_YBX1_TARGETS_DN			ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	MODULE_118	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52					REACTOME_CELL_CYCLE_MITOTIC			FEVR_CTNNB1_TARGETS_DN		MODULE_198		MODULE_18						RUIZ_TNC_TARGETS_DN	BIDUS_METASTASIS_UP	BENPORATH_ES_1	MODULE_3	MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252								AFFAR_YY1_TARGETS_DN
1894	ECT2	epithelial cell transforming sequence 2 oncogene		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP			VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP			MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M												KRIEG_HYPOXIA_NOT_VIA_KDM3A				SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP							SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	MITSIADES_RESPONSE_TO_APLIDIN_DN	ZHENG_GLIOBLASTOMA_PLASTICITY_UP									SHEPARD_CRUSH_AND_BURN_MUTANT_DN				LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN									RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP	BENPORATH_ES_1			GEORGES_TARGETS_OF_MIR192_AND_MIR215										
54908	CCDC99	coiled-coil domain containing 99		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES		BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP					MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M								ZHANG_TLX_TARGETS_36HR_DN							CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP		REACTOME_CELL_CYCLE																			REACTOME_CELL_CYCLE_MITOTIC													RUIZ_TNC_TARGETS_DN						WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP		
9585	KIF20B	kinesin family member 20B		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP									BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN							RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP						BLUM_RESPONSE_TO_SALIRASIB_DN			WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK													FURUKAWA_DUSP6_TARGETS_PCI35_DN									JOHNSTONE_PARVB_TARGETS_3_DN										TANG_SENESCENCE_TP53_TARGETS_DN		MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215										
5347	PLK1	polo-like kinase 1		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER		MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP		CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP		CROONQUIST_IL6_DEPRIVATION_DN		BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN				FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER	KANG_DOXORUBICIN_RESISTANCE_UP							REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3		WONG_EMBRYONIC_STEM_CELL_CORE			SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118			MODULE_52		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN			REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP			MODULE_198		MODULE_18									MODULE_3	MODULE_98			MODULE_252			REICHERT_MITOSIS_LIN9_TARGETS					AFFAR_YY1_TARGETS_DN
5888	RAD51	RAD51 homolog (S. cerevisiae)		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED	SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP		BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES	KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN		PUJANA_BRCA1_PCC_NETWORK											KRIEG_HYPOXIA_NOT_VIA_KDM3A						BURTON_ADIPOGENESIS_3			MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN						LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP	FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION	MODULE_198							RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN					MODULE_98	GEORGES_TARGETS_OF_MIR192_AND_MIR215		MODULE_252		ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR						
1163	CKS1B	CDC28 protein kinase regulatory subunit 1B		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54	KOBAYASHI_EGFR_SIGNALING_24HR_DN				MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	BENPORATH_CYCLING_GENES			NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN		GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP		GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP				HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M	PUJANA_BRCA1_PCC_NETWORK	CROONQUIST_NRAS_SIGNALING_DN				FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER								REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN	FUJII_YBX1_TARGETS_DN	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN		LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN			WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	LE_EGR2_TARGETS_UP		BENPORATH_PROLIFERATION		TARTE_PLASMA_CELL_VS_PLASMABLAST_DN						RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN									RHODES_UNDIFFERENTIATED_CANCER			MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				
55789	DEPDC1B	DEP domain containing 1B		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN															WHITFIELD_CELL_CYCLE_G2_M									PATIL_LIVER_CANCER		ZHAN_MULTIPLE_MYELOMA_PR_UP					SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP						FUJII_YBX1_TARGETS_DN													JOHNSTONE_PARVB_TARGETS_3_DN																													
113130	CDCA5	cell division cycle associated 5		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED				VECCHI_GASTRIC_CANCER_EARLY_UP			KONG_E2F3_TARGETS	CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE					HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP		GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN										PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A								WONG_EMBRYONIC_STEM_CELL_CORE	MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP									WHITEFORD_PEDIATRIC_CANCER_MARKERS								BENPORATH_PROLIFERATION											BENPORATH_ES_1							ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR		MORI_LARGE_PRE_BII_LYMPHOCYTE_UP				
90417	C15orf23	chromosome 15 open reading frame 23		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES																WINNEPENNINCKX_MELANOMA_METASTASIS_UP				WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP					PATIL_LIVER_CANCER																	FURUKAWA_DUSP6_TARGETS_PCI35_DN	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN								JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN	BENPORATH_PROLIFERATION										BIDUS_METASTASIS_UP														
9824	ARHGAP11A	Rho GTPase activating protein 11A		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54			DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED						BENPORATH_CYCLING_GENES					ODONNELL_TFRC_TARGETS_DN						RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP										PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP			PUJANA_CHEK2_PCC_NETWORK																			FURUKAWA_DUSP6_TARGETS_PCI35_DN									JOHNSTONE_PARVB_TARGETS_3_DN																			GEORGES_TARGETS_OF_MIR192_AND_MIR215										
221150	SKA3	spindle and kinetochore associated complex subunit 3		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP				CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN								RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																								CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP								SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP												JOHNSTONE_PARVB_TARGETS_3_DN																													
157313	CDCA2	cell division cycle associated 2		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP										LEE_EARLY_T_LYMPHOCYTE_UP																																												WHITEFORD_PEDIATRIC_CANCER_MARKERS	LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	SHEPARD_CRUSH_AND_BURN_MUTANT_DN													MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN												REICHERT_MITOSIS_LIN9_TARGETS					
90381	C15orf42	chromosome 15 open reading frame 42		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP											NUYTTEN_EZH2_TARGETS_DN																																												WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																											GEORGES_TARGETS_OF_MIR192_AND_MIR215										
151246	SGOL2	shugoshin-like 2 (S. pombe)		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP							ODONNELL_TFRC_TARGETS_DN			LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					WINNEPENNINCKX_MELANOMA_METASTASIS_UP				WHITFIELD_CELL_CYCLE_G2_M				FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP											CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE								ZHENG_GLIOBLASTOMA_PLASTICITY_UP								LINDGREN_BLADDER_CANCER_CLUSTER_1_DN		JOHNSTONE_PARVB_TARGETS_3_DN	REACTOME_CELL_CYCLE_MITOTIC																		GEORGES_TARGETS_OF_MIR192_AND_MIR215							CHICAS_RB1_TARGETS_GROWING			
64946	CENPH	centromere protein H		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED				VECCHI_GASTRIC_CANCER_EARLY_UP			KONG_E2F3_TARGETS		NUYTTEN_EZH2_TARGETS_DN			ZHANG_TLX_TARGETS_60HR_DN																						ZHANG_TLX_TARGETS_36HR_DN									REACTOME_CELL_CYCLE										WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN									REACTOME_CELL_CYCLE_MITOTIC			FEVR_CTNNB1_TARGETS_DN								MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN														CHICAS_RB1_TARGETS_GROWING			AFFAR_YY1_TARGETS_DN
64105	CENPK	centromere protein K		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN						MARSON_BOUND_BY_E2F4_UNSTIMULATED				VECCHI_GASTRIC_CANCER_EARLY_UP			KONG_E2F3_TARGETS					ZHANG_TLX_TARGETS_60HR_DN												GAVIN_FOXP3_TARGETS_CLUSTER_P6	MARKEY_RB1_ACUTE_LOF_DN				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP				ZHANG_TLX_TARGETS_36HR_DN								SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE	BURTON_ADIPOGENESIS_3				FUJII_YBX1_TARGETS_DN					WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN									REACTOME_CELL_CYCLE_MITOTIC											MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR			CHICAS_RB1_TARGETS_GROWING	ZHANG_TLX_TARGETS_UP		
151648	SGOL1	shugoshin-like 1 (S. pombe)		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN						MARSON_BOUND_BY_E2F4_UNSTIMULATED												ZHANG_TLX_TARGETS_60HR_DN								HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP														ZHANG_TLX_TARGETS_36HR_DN									REACTOME_CELL_CYCLE																			REACTOME_CELL_CYCLE_MITOTIC																										ZHANG_TLX_TARGETS_UP		
55646	LYAR	Ly1 antibody reactive homolog (mouse)		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP		DODD_NASOPHARYNGEAL_CARCINOMA_DN										VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES				ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																	ZHANG_TLX_TARGETS_36HR_DN																			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																			ZHANG_TLX_TARGETS_UP		
81610	FAM83D	family with sequence similarity 83, member D		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP			MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP				HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP			BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN																																																LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP										MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN							GEORGES_TARGETS_OF_MIR192_AND_MIR215										
144455	E2F7	E2F transcription factor 7		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP					BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP										LEE_EARLY_T_LYMPHOCYTE_UP			RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																					KRIEG_HYPOXIA_NOT_VIA_KDM3A										FUJII_YBX1_TARGETS_DN			ZHENG_GLIOBLASTOMA_PLASTICITY_UP		WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																				MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN																	
150468	CKAP2L	cytoskeleton associated protein 2-like		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP		CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN						CHANG_CYCLING_GENES	NUYTTEN_EZH2_TARGETS_DN		ODONNELL_TFRC_TARGETS_DN																																																																					GEORGES_TARGETS_OF_MIR192_AND_MIR215										
9590	AKAP12	A kinase (PRKA) anchor protein 12		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP					KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																									KRIEG_HYPOXIA_NOT_VIA_KDM3A																MODULE_118			MODULE_52		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP											RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN				MODULE_3												
729533	FAM72A	family with sequence similarity 72, member A		GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP								MARSON_BOUND_BY_E2F4_UNSTIMULATED																																																																																										
1829	DSG2	desmoglein 2			ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	DODD_NASOPHARYNGEAL_CARCINOMA_DN											CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP																																																											BENPORATH_ES_1													
26499	PLEK2	pleckstrin 2			ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER																																				ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR			FOURNIER_ACINAR_DEVELOPMENT_LATE_2																	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP																																									
54443	ANLN	anillin, actin binding protein				DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54		KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES		CHANG_CYCLING_GENES		BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN	ZHANG_TLX_TARGETS_60HR_DN			GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP			HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP		WINNEPENNINCKX_MELANOMA_METASTASIS_UP			MARKEY_RB1_ACUTE_LOF_DN	WHITFIELD_CELL_CYCLE_G2_M			ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP				ZHANG_TLX_TARGETS_36HR_DN								SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP							SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP		ZHENG_GLIOBLASTOMA_PLASTICITY_UP									SHEPARD_CRUSH_AND_BURN_MUTANT_DN						BENPORATH_PROLIFERATION														GEORGES_TARGETS_OF_MIR192_AND_MIR215	WU_APOPTOSIS_BY_CDKN1A_VIA_TP53							ZHANG_TLX_TARGETS_UP		
7167	TPI1	triosephosphate isomerase 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54										CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE				CAIRO_HEPATOBLASTOMA_CLASSES_UP				BLUM_RESPONSE_TO_SALIRASIB_DN	GAVIN_FOXP3_TARGETS_CLUSTER_P6														KRIEG_HYPOXIA_NOT_VIA_KDM3A																							JOHNSTONE_PARVB_TARGETS_3_DN													RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN																
908	CCT6A	chaperonin containing TCP1, subunit 6A (zeta 1)				DODD_NASOPHARYNGEAL_CARCINOMA_DN	MODULE_54															BERENJENO_TRANSFORMED_BY_RHOA_UP						RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP		CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK			FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP												SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP														WEST_ADRENOCORTICAL_TUMOR_UP	MODULE_52											TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18					RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN				MODULE_3					RHODES_UNDIFFERENTIATED_CANCER							
7371	UCK2	uridine-cytidine kinase 2				DODD_NASOPHARYNGEAL_CARCINOMA_DN		KOBAYASHI_EGFR_SIGNALING_24HR_DN	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP													BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP									PUJANA_BRCA1_PCC_NETWORK					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK		PATIL_LIVER_CANCER												MORI_IMMATURE_B_LYMPHOCYTE_DN		SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP						LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN		MODULE_52		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN				LINDGREN_BLADDER_CANCER_CLUSTER_3_UP					TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18									MODULE_3												
57082	CASC5	cancer susceptibility candidate 5				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED		HORIUCHI_WTAP_TARGETS_DN		VECCHI_GASTRIC_CANCER_EARLY_UP					NUYTTEN_EZH2_TARGETS_DN					LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP													FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP											CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE										WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN							SHEPARD_CRUSH_AND_BURN_MUTANT_DN		REACTOME_CELL_CYCLE_MITOTIC											MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN			BIDUS_METASTASIS_UP				GEORGES_TARGETS_OF_MIR192_AND_MIR215					REICHERT_MITOSIS_LIN9_TARGETS		CHICAS_RB1_TARGETS_GROWING			
162681	C18orf54	chromosome 18 open reading frame 54				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP			MARSON_BOUND_BY_E2F4_UNSTIMULATED																	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																												JOHNSTONE_PARVB_TARGETS_3_DN																			GEORGES_TARGETS_OF_MIR192_AND_MIR215										
10785	WDR4	WD repeat domain 4				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP						BASAKI_YBX1_TARGETS_UP						NUYTTEN_EZH2_TARGETS_DN							RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																					WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																					
7520	XRCC5	X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN														CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK							WONG_EMBRYONIC_STEM_CELL_CORE									LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN												MODULE_198												MODULE_98			MODULE_252								
6120	RPE	ribulose-5-phosphate-3-epimerase				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP								CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																																								JOHNSTONE_PARVB_TARGETS_3_DN																													
51133	KCTD3	potassium channel tetramerisation domain containing 3				DODD_NASOPHARYNGEAL_CARCINOMA_DN			KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP												NUYTTEN_EZH2_TARGETS_DN																													KRIEG_HYPOXIA_NOT_VIA_KDM3A																																				RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN																
10970	CKAP4	cytoskeleton-associated protein 4				DODD_NASOPHARYNGEAL_CARCINOMA_DN					CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP						CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																					SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																																						GEORGES_TARGETS_OF_MIR192_AND_MIR215										
81624	DIAPH3	diaphanous homolog 3 (Drosophila)				DODD_NASOPHARYNGEAL_CARCINOMA_DN						MARSON_BOUND_BY_E2F4_UNSTIMULATED			BASAKI_YBX1_TARGETS_UP					CHANG_CYCLING_GENES		BERENJENO_TRANSFORMED_BY_RHOA_UP	ODONNELL_TFRC_TARGETS_DN			LEE_EARLY_T_LYMPHOCYTE_UP		RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP									WHITFIELD_CELL_CYCLE_G2_M																SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP							SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP				WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN								JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN																									AFFAR_YY1_TARGETS_DN
8833	GMPS	guanine monphosphate synthetase				DODD_NASOPHARYNGEAL_CARCINOMA_DN							SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP				CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN											RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP					CROONQUIST_IL6_DEPRIVATION_DN	WINNEPENNINCKX_MELANOMA_METASTASIS_UP					PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK						PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP									MITSIADES_RESPONSE_TO_APLIDIN_DN				MODULE_118			MODULE_52				JOHNSTONE_PARVB_TARGETS_3_DN				FEVR_CTNNB1_TARGETS_DN				MODULE_18					RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN				MODULE_3									CHICAS_RB1_TARGETS_GROWING			
3939	LDHA	lactate dehydrogenase A				DODD_NASOPHARYNGEAL_CARCINOMA_DN								HORIUCHI_WTAP_TARGETS_DN			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP										HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP			BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK					KRIEG_HYPOXIA_NOT_VIA_KDM3A																																				RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN																
2590	GALNT2	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)				DODD_NASOPHARYNGEAL_CARCINOMA_DN									BASAKI_YBX1_TARGETS_UP																				BLUM_RESPONSE_TO_SALIRASIB_DN				PUJANA_BRCA1_PCC_NETWORK																																																															
25902	MTHFD1L	methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like				DODD_NASOPHARYNGEAL_CARCINOMA_DN										VECCHI_GASTRIC_CANCER_EARLY_UP												RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																					KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
23446	SLC44A1	solute carrier family 44, member 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN															NUYTTEN_EZH2_TARGETS_DN																																	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP																																																
54583	EGLN1	egl nine homolog 1 (C. elegans)				DODD_NASOPHARYNGEAL_CARCINOMA_DN																						RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																						KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
6624	FSCN1	fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)				DODD_NASOPHARYNGEAL_CARCINOMA_DN																								SMID_BREAST_CANCER_BASAL_UP																				KRIEG_HYPOXIA_NOT_VIA_KDM3A																							JOHNSTONE_PARVB_TARGETS_3_DN																													
3842	TNPO1	transportin 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																WHITFIELD_CELL_CYCLE_G2_M									PATIL_LIVER_CANCER																					WEST_ADRENOCORTICAL_TUMOR_UP					JOHNSTONE_PARVB_TARGETS_3_DN						MODULE_198		MODULE_18						RUIZ_TNC_TARGETS_DN			MODULE_3	MODULE_98			MODULE_252								
121441	NEDD1	neural precursor cell expressed, developmentally down-regulated 1				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																								ZHANG_TLX_TARGETS_36HR_DN								SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	REACTOME_CELL_CYCLE																			REACTOME_CELL_CYCLE_MITOTIC																		GEORGES_TARGETS_OF_MIR192_AND_MIR215										
7532	YWHAG	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																	REACTOME_CELL_CYCLE																			REACTOME_CELL_CYCLE_MITOTIC																												
7088	TLE1	transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)				DODD_NASOPHARYNGEAL_CARCINOMA_DN																																																									ZHENG_GLIOBLASTOMA_PLASTICITY_UP																MODULE_198												MODULE_98											
10272	FSTL3	follistatin-like 3 (secreted glycoprotein)					MODULE_54																																																																																															
22943	DKK1	dickkopf homolog 1 (Xenopus laevis)						KOBAYASHI_EGFR_SIGNALING_24HR_DN						HORIUCHI_WTAP_TARGETS_DN	BASAKI_YBX1_TARGETS_UP															SMID_BREAST_CANCER_BASAL_UP																	PATIL_LIVER_CANCER													FUJII_YBX1_TARGETS_DN																											RUIZ_TNC_TARGETS_DN															
8061	FOSL1	FOS-like antigen 1						KOBAYASHI_EGFR_SIGNALING_24HR_DN								VECCHI_GASTRIC_CANCER_EARLY_UP						BERENJENO_TRANSFORMED_BY_RHOA_UP								SMID_BREAST_CANCER_BASAL_UP														FOURNIER_ACINAR_DEVELOPMENT_LATE_2								MISSIAGLIA_REGULATED_BY_METHYLATION_DN									SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP																		MODULE_198								RUIZ_TNC_TARGETS_DN				MODULE_98			MODULE_252								
3655	ITGA6	integrin, alpha 6						KOBAYASHI_EGFR_SIGNALING_24HR_DN													NUYTTEN_EZH2_TARGETS_DN	BERENJENO_TRANSFORMED_BY_RHOA_UP								SMID_BREAST_CANCER_BASAL_UP																																				MODULE_118			MODULE_52												MODULE_18									MODULE_3												
2707	GJB3	gap junction protein, beta 3, 31kDa						KOBAYASHI_EGFR_SIGNALING_24HR_DN																						SMID_BREAST_CANCER_BASAL_UP																																															FEVR_CTNNB1_TARGETS_DN																									AFFAR_YY1_TARGETS_DN
55157	DARS2	aspartyl-tRNA synthetase 2, mitochondrial							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP		MARSON_BOUND_BY_E2F4_UNSTIMULATED																																														WONG_EMBRYONIC_STEM_CELL_CORE							WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																					
10642	IGF2BP1	insulin-like growth factor 2 mRNA binding protein 1							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP										KONG_E2F3_TARGETS																												PATIL_LIVER_CANCER																																																							
5725	PTBP1	polypyrimidine tract binding protein 1							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP												NUYTTEN_EZH2_TARGETS_DN																		PUJANA_BRCA1_PCC_NETWORK																																																															
9689	BZW1	basic leucine zipper and W2 domains 1							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																				RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP										PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK					KRIEG_HYPOXIA_NOT_VIA_KDM3A						BURTON_ADIPOGENESIS_3																																														
5707	PSMD1	proteasome (prosome, macropain) 26S subunit, non-ATPase, 1							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																														REACTOME_CELL_CYCLE																			REACTOME_CELL_CYCLE_MITOTIC																												
100128191	LOC100128191	uncharacterized LOC100128191							KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP																																																																																													
5570	PKIB	protein kinase (cAMP-dependent, catalytic) inhibitor beta								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																																																	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP																											
114904	C1QTNF6	C1q and tumor necrosis factor related protein 6								DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP																																																																																												
84002	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5									CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP										NUYTTEN_EZH2_TARGETS_DN																																																																							GEORGES_TARGETS_OF_MIR192_AND_MIR215										
5315	PKM2	pyruvate kinase, muscle									CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP																								BLUM_RESPONSE_TO_SALIRASIB_DN															KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
6286	S100P	S100 calcium binding protein P									CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP																																				PATIL_LIVER_CANCER																			MODULE_118																		POOLA_INVASIVE_BREAST_CANCER_UP																		
143458	LDLRAD3	low density lipoprotein receptor class A domain containing 3									CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP																																																																																											
6464	SHC1	SHC (Src homology 2 domain containing) transforming protein 1										MARSON_BOUND_BY_E2F4_UNSTIMULATED						BENPORATH_CYCLING_GENES																													PATIL_LIVER_CANCER																																																							
23596	OPN3	opsin 3										MARSON_BOUND_BY_E2F4_UNSTIMULATED																							BLUM_RESPONSE_TO_SALIRASIB_DN																																																																			
84529	C15orf41	chromosome 15 open reading frame 41										MARSON_BOUND_BY_E2F4_UNSTIMULATED																																			PATIL_LIVER_CANCER																																																							
56938	ARNTL2	aryl hydrocarbon receptor nuclear translocator-like 2												HORIUCHI_WTAP_TARGETS_DN			CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP																																																														GEORGES_TARGETS_OF_MIR192_AND_MIR215										
3918	LAMC2	laminin, gamma 2													BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP						BERENJENO_TRANSFORMED_BY_RHOA_UP								SMID_BREAST_CANCER_BASAL_UP									PUJANA_BRCA1_PCC_NETWORK					FOURNIER_ACINAR_DEVELOPMENT_LATE_2	PUJANA_CHEK2_PCC_NETWORK																																																									
56937	PMEPA1	prostate transmembrane protein, androgen induced 1													BASAKI_YBX1_TARGETS_UP	VECCHI_GASTRIC_CANCER_EARLY_UP																																		KRIEG_HYPOXIA_NOT_VIA_KDM3A														FURUKAWA_DUSP6_TARGETS_PCI35_DN																																						
51022	GLRX2	glutaredoxin 2													BASAKI_YBX1_TARGETS_UP													RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP						WINNEPENNINCKX_MELANOMA_METASTASIS_UP																																		WEST_ADRENOCORTICAL_TUMOR_UP																																		
390	RND3	Rho family GTPase 3													BASAKI_YBX1_TARGETS_UP														RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	SMID_BREAST_CANCER_BASAL_UP														FOURNIER_ACINAR_DEVELOPMENT_LATE_2																			ZHENG_GLIOBLASTOMA_PLASTICITY_UP			MODULE_118			MODULE_52												MODULE_18									MODULE_3												
5708	PSMD2	proteasome (prosome, macropain) 26S subunit, non-ATPase, 2													BASAKI_YBX1_TARGETS_UP																																								REACTOME_CELL_CYCLE							MITSIADES_RESPONSE_TO_APLIDIN_DN												REACTOME_CELL_CYCLE_MITOTIC					MODULE_198												MODULE_98			MODULE_252	RHODES_UNDIFFERENTIATED_CANCER							
7020	TFAP2A	transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)														VECCHI_GASTRIC_CANCER_EARLY_UP		BENPORATH_CYCLING_GENES											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																		MODULE_198		MODULE_18										MODULE_98											
5268	SERPINB5	serpin peptidase inhibitor, clade B (ovalbumin), member 5														VECCHI_GASTRIC_CANCER_EARLY_UP														SMID_BREAST_CANCER_BASAL_UP																																																																								
3875	KRT18	keratin 18														VECCHI_GASTRIC_CANCER_EARLY_UP																																																		MODULE_118			MODULE_52												MODULE_18									MODULE_3												
3855	KRT7	keratin 7														VECCHI_GASTRIC_CANCER_EARLY_UP																																																					MODULE_52																					MODULE_3												
54830	NUP62CL	nucleoporin 62kDa C-terminal like														VECCHI_GASTRIC_CANCER_EARLY_UP																																																																																						
3308	HSPA4	heat shock 70kDa protein 4															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN					BERENJENO_TRANSFORMED_BY_RHOA_UP		ZHANG_TLX_TARGETS_60HR_DN				RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP					WINNEPENNINCKX_MELANOMA_METASTASIS_UP					PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK																																			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN									BENPORATH_ES_1													
10512	SEMA3C	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN												RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP								MARKEY_RB1_ACUTE_LOF_DN																																MODULE_52												MODULE_18	KIM_WT1_TARGETS_DN																				
7416	VDAC1	voltage-dependent anion channel 1															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																						PUJANA_BRCA1_PCC_NETWORK											KRIEG_HYPOXIA_NOT_VIA_KDM3A																		WEST_ADRENOCORTICAL_TUMOR_UP			LINDGREN_BLADDER_CANCER_CLUSTER_1_DN									TARTE_PLASMA_CELL_VS_PLASMABLAST_DN						RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP														
8942	KYNU	kynureninase															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																						PUJANA_BRCA1_PCC_NETWORK																																									TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	MODULE_18																					
6611	SMS	spermine synthase															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																											FOURNIER_ACINAR_DEVELOPMENT_LATE_2						KRIEG_HYPOXIA_NOT_VIA_KDM3A																															MODULE_18					RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN		BIDUS_METASTASIS_UP	BENPORATH_ES_1													
23170	TTLL12	tubulin tyrosine ligase-like family, member 12															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																											FOURNIER_ACINAR_DEVELOPMENT_LATE_2																																					MODULE_18								BENPORATH_ES_1													
226	ALDOA	aldolase A, fructose-bisphosphate															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																														PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
5887	RAD23B	RAD23 homolog B (S. cerevisiae)															CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN																																									WONG_EMBRYONIC_STEM_CELL_CORE		FUJII_YBX1_TARGETS_DN								WEST_ADRENOCORTICAL_TUMOR_UP																																		
7050	TGIF1	TGFB-induced factor homeobox 1																BENPORATH_CYCLING_GENES				BERENJENO_TRANSFORMED_BY_RHOA_UP																WHITFIELD_CELL_CYCLE_G2_M																				WONG_EMBRYONIC_STEM_CELL_CORE																					MODULE_198		MODULE_18	KIM_WT1_TARGETS_DN									MODULE_98											
3267	AGFG1	ArfGAP with FG repeats 1																BENPORATH_CYCLING_GENES										RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP			CAIRO_HEPATOBLASTOMA_CLASSES_UP													FOURNIER_ACINAR_DEVELOPMENT_LATE_2																																		BENPORATH_PROLIFERATION													MODULE_98											
54407	SLC38A2	solute carrier family 38, member 2																BENPORATH_CYCLING_GENES											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																					KRIEG_HYPOXIA_NOT_VIA_KDM3A												MITSIADES_RESPONSE_TO_APLIDIN_DN			WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																	KIM_WT1_TARGETS_DN																				
11080	DNAJB4	DnaJ (Hsp40) homolog, subfamily B, member 4																BENPORATH_CYCLING_GENES												SMID_BREAST_CANCER_BASAL_UP									PUJANA_BRCA1_PCC_NETWORK																																											KIM_WT1_TARGETS_DN										GEORGES_TARGETS_OF_MIR192_AND_MIR215										
10226	PLIN3	perilipin 3																BENPORATH_CYCLING_GENES													CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK																																																															
653820	FAM72B	family with sequence similarity 72, member B																		CHANG_CYCLING_GENES																											PATIL_LIVER_CANCER																																																							
3688	ITGB1	integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)																			NUYTTEN_EZH2_TARGETS_DN						GOLDRATH_ANTIGEN_RESPONSE	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																			TARTE_PLASMA_CELL_VS_PLASMABLAST_DN		KIM_WT1_TARGETS_DN										GEORGES_TARGETS_OF_MIR192_AND_MIR215										
9633	MTL5	metallothionein-like 5, testis-specific (tesmin)																			NUYTTEN_EZH2_TARGETS_DN																																																																																	
5223	PGAM1	phosphoglycerate mutase 1 (brain)																				BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE								BLUM_RESPONSE_TO_SALIRASIB_DN															KRIEG_HYPOXIA_NOT_VIA_KDM3A												MITSIADES_RESPONSE_TO_APLIDIN_DN																																								
54206	ERRFI1	ERBB receptor feedback inhibitor 1																				BERENJENO_TRANSFORMED_BY_RHOA_UP					GOLDRATH_ANTIGEN_RESPONSE																																																																											
92521	SPECC1	sperm antigen with calponin homology and coiled-coil domains 1																				BERENJENO_TRANSFORMED_BY_RHOA_UP																																																						LE_EGR2_TARGETS_UP																										
64065	PERP	PERP, TP53 apoptosis effector																									GOLDRATH_ANTIGEN_RESPONSE			SMID_BREAST_CANCER_BASAL_UP							MARKEY_RB1_ACUTE_LOF_DN													KRIEG_HYPOXIA_NOT_VIA_KDM3A																																KIM_WT1_TARGETS_DN										GEORGES_TARGETS_OF_MIR192_AND_MIR215										
55276	PGM2	phosphoglucomutase 2																									GOLDRATH_ANTIGEN_RESPONSE																							KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
493869	GPX8	glutathione peroxidase 8 (putative)																										RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																												JOHNSTONE_PARVB_TARGETS_3_DN																													
57099	AVEN	apoptosis, caspase activation inhibitor																										RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP																																																																										
113146	AHNAK2	AHNAK nucleoprotein 2																											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP														NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP																																																											
5339	PLEC	plectin																											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																	MITSIADES_RESPONSE_TO_APLIDIN_DN							MODULE_52												MODULE_18																					
29766	TMOD3	tropomodulin 3 (ubiquitous)																											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																																									
221393	GPR115	G protein-coupled receptor 115																											RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP																																																																									
57707	KIAA1609	KIAA1609																												SMID_BREAST_CANCER_BASAL_UP	CAIRO_HEPATOBLASTOMA_CLASSES_UP																																																																							
54541	DDIT4	DNA-damage-inducible transcript 4																												SMID_BREAST_CANCER_BASAL_UP																				KRIEG_HYPOXIA_NOT_VIA_KDM3A																MODULE_118			MODULE_52												MODULE_18	KIM_WT1_TARGETS_DN																	CHICAS_RB1_TARGETS_GROWING			
51129	ANGPTL4	angiopoietin-like 4																												SMID_BREAST_CANCER_BASAL_UP																				KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
4188	MDFI	MyoD family inhibitor																												SMID_BREAST_CANCER_BASAL_UP																						MISSIAGLIA_REGULATED_BY_METHYLATION_DN																																																		
3872	KRT17	keratin 17																												SMID_BREAST_CANCER_BASAL_UP																																																	MODULE_198												MODULE_98			MODULE_252								
3854	KRT6B	keratin 6B																												SMID_BREAST_CANCER_BASAL_UP																																																	MODULE_198												MODULE_98											
3868	KRT16	keratin 16																												SMID_BREAST_CANCER_BASAL_UP																																																																								
3853	KRT6A	keratin 6A																												SMID_BREAST_CANCER_BASAL_UP																																																																								
3887	KRT81	keratin 81																												SMID_BREAST_CANCER_BASAL_UP																																																																								
23480	SEC61G	Sec61 gamma subunit																													CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK					KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
10155	TRIM28	tripartite motif containing 28																													CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK								PATIL_LIVER_CANCER				PUJANA_BRCA2_PCC_NETWORK	MISSIAGLIA_REGULATED_BY_METHYLATION_DN	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP																								FEVR_CTNNB1_TARGETS_DN																									
7417	VDAC2	voltage-dependent anion channel 2																													CAIRO_HEPATOBLASTOMA_CLASSES_UP								PUJANA_BRCA1_PCC_NETWORK																																																			MODULE_3												
2683	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1																																				WHITFIELD_CELL_CYCLE_G2_M																																																																
143244	EIF5AL1	eukaryotic translation initiation factor 5A-like 1																																					PUJANA_BRCA1_PCC_NETWORK						PUJANA_CHEK2_PCC_NETWORK																				WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN																																					
2526	FUT4	fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)																																					PUJANA_BRCA1_PCC_NETWORK																																																															
64866	CDCP1	CUB domain containing protein 1																																										FOURNIER_ACINAR_DEVELOPMENT_LATE_2						KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
4017	LOXL2	lysyl oxidase-like 2																																													PATIL_LIVER_CANCER			KRIEG_HYPOXIA_NOT_VIA_KDM3A																MODULE_118			MODULE_52		LINDGREN_BLADDER_CANCER_CLUSTER_1_DN																			MODULE_3												
135228	CD109	CD109 molecule																																													PATIL_LIVER_CANCER																																																							
645166	LOC645166	lymphocyte-specific protein 1 pseudogene																																													PATIL_LIVER_CANCER																																																							
54509	RHOF	ras homolog gene family, member F (in filopodia)																																																KRIEG_HYPOXIA_NOT_VIA_KDM3A																																		POOLA_INVASIVE_BREAST_CANCER_UP																		
7975	MAFK	v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)																																																KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
54498	SMOX	spermine oxidase																																																KRIEG_HYPOXIA_NOT_VIA_KDM3A																																																				
5099	PCDH7	protocadherin 7																																																		MISSIAGLIA_REGULATED_BY_METHYLATION_DN																																								GEORGES_TARGETS_OF_MIR192_AND_MIR215							CHICAS_RB1_TARGETS_GROWING			
64841	GNPNAT1	glucosamine-phosphate N-acetyltransferase 1																																																																											FEVR_CTNNB1_TARGETS_DN																									
23184	MESDC2	mesoderm development candidate 2																																																																																			MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN																	
23301	EHBP1	EH domain binding protein 1																																																																																				RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN																
2706	GJB2	gap junction protein, beta 2, 26kDa																																																																																																				
4643	MYO1E	myosin IE																																																																																																				
84985	FAM83A	family with sequence similarity 83, member A																																																																																																				
728833	FAM72D	family with sequence similarity 72, member D																																																																																																				
130340	AP1S3	adaptor-related protein complex 1, sigma 3 subunit																																																																																																				
140576	S100A16	S100 calcium binding protein A16																																																																																																				
5045	FURIN	furin (paired basic amino acid cleaving enzyme)																																																																																																				
3484	IGFBP1	insulin-like growth factor binding protein 1																																																																																																				
84951	TNS4	tensin 4																																																																																																				
2318	FLNC	filamin C, gamma																																																																																																				
400745	SH2D5	SH2 domain containing 5																																																																																																				
51458	RHCG	Rh family, C glycoprotein																																																																																																				
171177	RHOV	ras homolog gene family, member V																																																																																																				
89886	SLAMF9	SLAM family member 9																																																																																																				
4862	NPAS2	neuronal PAS domain protein 2																																																																																																				
113026	PLCD3	phospholipase C, delta 3																																																																																																				
57522	SRGAP1	SLIT-ROBO Rho GTPase activating protein 1																																																																																																				
9564	BCAR1	breast cancer anti-estrogen resistance 1																																																																																																				
84929	FIBCD1	fibrinogen C domain containing 1																																																																																																				
1072	CFL1	cofilin 1 (non-muscle)																																																																																																				
27076	LYPD3	LY6/PLAUR domain containing 3																																																																																																				
4923	NTSR1	neurotensin receptor 1 (high affinity)																																																																																																				
3754	KCNF1	potassium voltage-gated channel, subfamily F, member 1																																																																																																				
9578	CDC42BPB	CDC42 binding protein kinase beta (DMPK-like)																																																																																																				
391059	FRRS1	ferric-chelate reductase 1																																																																																																				
285643	KIF4B	kinesin family member 4B																																																																																																				
11077	HSF2BP	heat shock transcription factor 2 binding protein																																																																																																				
117854	TRIM6	tripartite motif containing 6																																																																																																				
1821	DRP2	dystrophin related protein 2																																																																																																				
116211	TM4SF19	transmembrane 4 L six family member 19																																																																																																				
339977	LRRC66	leucine rich repeat containing 66																																																																																																				
200407	CREG2	cellular repressor of E1A-stimulated genes 2																																																																																																				
441531	PGAM4	phosphoglycerate mutase family member 4																																																																																																				
648791	PPP1R3G	protein phosphatase 1, regulatory subunit 3G																																																																																																				
286887	KRT6C	keratin 6C																																																																																																				
51054	PLEKHA8P1	pleckstrin homology domain containing, family A member 8 pseudogene 1																																																																																																				
348487	FAM131C	family with sequence similarity 131, member C																																																																																																				
100131726	LOC100131726	HCC-related HCC-C11_v3																																																																																																				
